Perimeter Medical Imaging AI (PINK) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
15 May, 2026Opening remarks and agenda
Meeting opened with a welcome, explanation of virtual procedures, and confirmation of recording consent.
Chair Suzanne Foster assumed the role of meeting chair and outlined participation rules for guests and shareholders.
Secretary and scrutineer roles were assigned, and the agenda and notice of meeting were confirmed as distributed.
Corporate governance
Quorum was confirmed as present, allowing the meeting to proceed with official business.
Voting procedures were explained, with electronic ballots open for all motions.
Financial performance review
Financial statements for the years ended December 31, 2024, and December 31, 2023, along with the auditor's report, were presented as received by shareholders.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Perimeter Medical Imaging AI
- Directors and auditor were elected, financials reviewed, and all motions passed by electronic vote.PINK
AGM 202415 May 2026 - FDA-approved AI imaging device launches commercialization, targeting rapid market expansion.PINK
2026 Bloom Burton & Co. Healthcare Investor Conference21 Apr 2026 - Record revenue growth and FDA approval for Claire OCT mark a pivotal year of transformation.PINK
Q4 20252 Apr 2026 - AI-powered imaging platform drives better cancer surgery outcomes and scalable recurring revenue.PINK
Investor presentation25 Mar 2026 - AI-powered OCT imaging is transforming surgical outcomes and driving commercial growth.PINK
Investor Update3 Feb 2026 - Revenue up 83% YoY, net loss down 35%, and pivotal B-Series OCT trial ahead of schedule.PINK
Q2 20241 Feb 2026 - Q3 revenue up 142% as S-Series OCT gains traction; pivotal B-Series trial completed.PINK
Q3 202414 Jan 2026 - Pivotal trial met its endpoint, paving the way for FDA submission and commercial launch in 2025.PINK
Status Update13 Jan 2026 - AI-powered imaging device reduces cancer surgery re-operations and drives recurring revenue.PINK
Small Cap Growth Virtual Investor Conference 202529 Dec 2025